Joseph Edelman – ADMA history
- Issuer:
- ADMA BIOLOGICS INC
- Quarters tracked:
- 39 (Q3 2016 → Q1 2026)
- Current shares:
- 467,233
- Current value:
- $4.21M
- Peak shares:
- 16,584,802 (Q1 2020)
- Overall change:
- -36%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 467,233 | $4.21M | $9.01 | -416,235 | -47% |
| Q4 2025 | 883,468 | $16.11M | $18.24 | -270,000 | -23% |
| Q3 2025 | 1,153,468 | $16.91M | $14.66 | -150,000 | -12% |
| Q2 2025 | 1,303,468 | $23.74M | $18.21 | -69,765 | -5% |
| Q1 2025 | 1,373,233 | $27.25M | $19.84 | +482,953 | +54% |
| Q4 2024 | 890,280 | $15.27M | $17.15 | -169,920 | -16% |
| Q3 2024 | 1,060,200 | $21.19M | $19.99 | -1,710,800 | -62% |
| Q2 2024 | 2,771,000 | $30.98M | $11.18 | -3,662,369 | -57% |
| Q1 2024 | 6,433,369 | $42.46M | $6.60 | 0 | 0% |
| Q4 2023 | 6,433,369 | $29.08M | $4.52 | -550,950 | -8% |
| Q3 2023 | 6,984,319 | $25.00M | $3.58 | -4,915,936 | -41% |
| Q2 2023 | 11,900,255 | $43.91M | $3.69 | 0 | 0% |
| Q1 2023 | 11,900,255 | $39.39M | $3.31 | 0 | 0% |
| Q4 2022 | 11,900,255 | $46.17M | $3.88 | +966,868 | +9% |
| Q3 2022 | 10,933,387 | $26.57M | $2.43 | -587,715 | -5% |
| Q2 2022 | 11,521,102 | $22.81M | $1.98 | -412,285 | -3% |
| Q1 2022 | 11,933,387 | $21.84M | $1.83 | 0 | 0% |
| Q4 2021 | 11,933,387 | $16.83M | $1.41 | -1,328,988 | -10% |
| Q3 2021 | 13,262,375 | $14.99M | $1.13 | -3,322,427 | -20% |
| Q2 2021 | 16,584,802 | $26.54M | $1.60 | 0 | 0% |
| Q1 2021 | 16,584,802 | $29.19M | $1.76 | 0 | 0% |
| Q4 2020 | 16,584,802 | $32.34M | $1.95 | 0 | 0% |
| Q3 2020 | 16,584,802 | $39.64M | $2.39 | 0 | 0% |
| Q2 2020 | 16,584,802 | $48.59M | $2.93 | 0 | 0% |
| Q1 2020 | 16,584,802 | $47.76M | $2.88 | +5,063,700 | +44% |
| Q4 2019 | 11,521,102 | $46.08M | $4.00 | 0 | 0% |
| Q3 2019 | 11,521,102 | $51.27M | $4.45 | 0 | 0% |
| Q2 2019 | 11,521,102 | $44.59M | $3.87 | +5,000,000 | +77% |
| Q1 2019 | 6,521,102 | $24.71M | $3.79 | 0 | 0% |
| Q4 2018 | 6,521,102 | $14.54M | $2.23 | 0 | 0% |
| Q3 2018 | 6,521,102 | $40.50M | $6.21 | 0 | 0% |
| Q2 2018 | 6,521,102 | $29.41M | $4.51 | +2,700,000 | +71% |
| Q1 2018 | 3,821,102 | $17.58M | $4.60 | 0 | 0% |
| Q4 2017 | 3,821,102 | $12.27M | $3.21 | +3,100,000 | +430% |
| Q3 2017 | 721,102 | $2.22M | $3.08 | 0 | 0% |
| Q2 2017 | 721,102 | $2.77M | $3.84 | 0 | 0% |
| Q1 2017 | 721,102 | $3.52M | $4.88 | 0 | 0% |
| Q4 2016 | 721,102 | $3.69M | $5.12 | -13,691 | -2% |
| Q3 2016 | 734,793 | $5.33M | $7.25 | — | NEW |